Everfront Biotech to Showcase New Drug Development Achievements at BIO 2024

SAN DIEGO - May 31, 2024 - PRLog -- Everfront Biotech is set to participate in the North American Biotechnology Exhibition (BIO 2024), held in San Diego, USA, from June 3 to June 6, 2024. As the world's largest international biotechnology industry exhibition and forum, it is regarded as the annual event of the global biotech community. This year, Everfront Biotech will join the Taiwan Biotechnology Delegation, exhibiting in the Taiwan Pavilion (booth numbers: 1817 and 1917), alongside 54 other elite biotech companies from Taiwan.

During the exhibition, Dr. Jui-Hao Li, Director of Clinical Medicine Research at Everfront Biotech, will deliver two brief presentations. These presentations will highlight the company's recent clinical drug developments and reveal Phase I/IIa clinical data for Cerebraca^® Wafer, a new drug for treating brain cancer. The goal is to align with international pharmaceutical companies and seek more global collaboration opportunities. We cordially invite you to visit our booth during the event to discuss your challenges in new drug development, explore potential collaboration opportunities, and embark on a journey to successful drug development with us.
more: https://www.efbiotech.com/wordpress/?page_id=7368